Company / Working Capital
Immuneering Corp Working Capital History
FY2021-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$81.2M
FY2023
5-year range
$81.2M / $146.7M
FY2021-FY2023
Trend
-19.3%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $147M to $81M over the past 2 years.
Based on SEC 10-K filings.
$81M in FY2023.
Declined from $147M to $81M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, working capital decreased 19.3% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -7.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | $81.2M | -19.3% |
| FY2022 | $100.7M | -31.4% |
| FY2021 | $146.7M | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026